Drugs / CLAG Regimen
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00955916 Background | Aug 2009 → Dec 2012 | leukemia | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLAG Regimen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00955916 ↗ |
| Route | Subcutaneous | “300 mcg subcutaneous (SC) for 6 days” NCT00955916 ↗ |